Bosh sahifaDEVA • IST
add
Deva Holding AS
Yopilish kursi
67,90 ₺
Yillik diapazon
51,00 ₺ - 81,75 ₺
Bozor kapitalizatsiyasi
13,58 mlrd TRY
Oʻrtacha hajm
608,21 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
IST
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (TRY) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 5,49 mlrd | -2,19% |
Joriy xarajat | 1,74 mlrd | 2,67% |
Sof foyda | -1,34 mlrd | -524,24% |
Sof foyda marjasi | -24,48 | -537,50% |
Har bir ulushga tushum | — | — |
EBITDA | 622,26 mln | -48,71% |
Amaldagi soliq stavkasi | -294,28% | — |
Balans
Jami aktivlari
Jami passivlari
| (TRY) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 3,59 mlrd | 26,49% |
Jami aktivlari | 37,63 mlrd | -3,31% |
Jami passivlari | 11,31 mlrd | -3,14% |
Umumiy kapital | 26,32 mlrd | — |
Tarqatilgan aksiyalar | 200,02 mln | — |
Narxi/balansdagi bahosi | 0,52 | — |
Aktivlardan daromad | -0,61% | — |
Kapitaldan daromad | -0,70% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (TRY) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -1,34 mlrd | -524,24% |
Operatsiyalardan naqd pul | 1,49 mlrd | 27,32% |
Sarmoyadan naqd pul | -838,87 mln | -130,98% |
Moliyadan naqd pul | 260,62 mln | 117,90% |
Naqd pulning sof oʻzgarishi | 885,62 mln | 206,74% |
Boʻsh pul | -165,38 mln | 95,31% |
Haqida
DEVA Holding A.Ş. is a leading Turkish pharmaceutical company founded in 1958. As of 2024, it ranked 3rd in unit sales and 6th in TL sales in Turkey’s pharmaceutical market.
The company operates three EU GMP- and US FDA-approved facilities in Çerkezköy and Kartepe, with an annual production capacity of 620 million units. DEVA’s portfolio covers 10 therapeutic areas, including cardiovascular, dermatology, ophthalmology, hematology, and anti-infectives, and includes 1,404 registered products across 82 countries.
Recognized as Turkey’s top pharmaceutical company in R&D spending by Turkishtime’s 2024 R&D 250 Report, DEVA employs over 500 researchers and 3,000 staff in total. Guided by sustainability and innovation, the company focuses on developing accessible, effective, and environmentally responsible healthcare solutions for both domestic and global markets. Wikipedia
Tashkil etilgan
22-sen, 1958
Sayt
Xodimlar soni
3 023
